Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2026 Q2 | Jul 1, 2026 | Protean Select | - | -1.8% | BAKKA.OL, CINT.ST, INDU-B.ST, SKA-B.ST, STORY-B.ST, TEL2-B.ST, TELIA.ST, TRUE-B.ST | AI, Construction, defense, infrastructure, Nordics, small caps, Telecom, valuation | SKA-B.ST TRUE-B.ST INDU-B.ST |
View | |
| 2026 Q2 | Jul 1, 2026 | Protean Small Cap | - | 2.5% | ALFA.ST, ATCO-A.ST, BAKKA.OL, BEIJ-B.ST, BIOG-B.ST, BTS-B.ST, CINT.ST, DEVYSER.ST, EPRO-B.ST, INDU-B.ST, PNDORA.CO, SKA-B.ST, STORY-B.ST, TELIA.ST, TRUE-B.ST | AI, defense, infrastructure, M&A, Nordics, small caps, Telecom, value | TELIA.ST SKA-B.ST TRUE-B.ST INDU-B.ST |
View | |
| 2025 Q3 | Oct 1, 2025 | Protean Select | - | 6.7% | ARJO-B.ST, BALD-B.ST, BOULE.ST, CHMO.CO, COLO-B.CO, DEMANT.CO, DEVYSER.ST, EAST.ST, EKTA-B.ST, ELUX-B.ST, GETI-B.ST, GRNGS.ST, HM-B.ST, INDU-A.ST, LUMI.ST, LUN.CO, MTG-B.ST, NIMB.ST, RUSTA.ST, SDIP.ST, SINCH.ST, SKA-B.ST, SWED-A.ST, VIM.ST, VITRO.ST | active management, Medtech, Nordics, Quality, SmallCap, value | The fund has built significant positions in Nordic MedTech companies, representing about 18% of the portfolio across 10 names. The manager believes they are early in picking up high-quality businesses that have fallen from grace, particularly Danish large-caps Demant and Coloplast where valuations have become sensible with triggers around the corner. | View | |
| 2025 Q3 | Oct 1, 2025 | Protean Small Cap | - | 11.8% | ARJO-B.ST, ASSA-B.ST, BALD-B.ST, BOUL.ST, CHMO.CO, COLO-B.ST, DEMANT.CO, DEVYSER.ST, EAST.ST, EKTA-B.ST, ELUX-B.ST, GETI-B.ST, GRNGS.ST, HM-B.ST, INDU-A.ST, INVE-B.ST, LUMI.ST, LUN-B.ST, MTG-B.ST, NESTE.HE, NIMB.ST, RUSTA.ST, SDIP.ST, SINCH.ST, SKA-B.ST, SWED-A.ST, VIMIAN.ST, VITR.ST | active management, Medtech, Nordic, Quality, small cap, value | The fund has built significant positions in Nordic MedTech companies, particularly Danish large-caps Demant and Coloplast, believing the market is approaching a bottoming process with sensible valuations and upcoming catalysts. The manager acknowledges being early in picking up high-quality businesses that have fallen from grace, with about 18% of the fund invested across 10 Nordic MedTech names. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Fund Letters | Protean Small Cap | Skanska AB | Engineering & Construction | Construction & Engineering | Bull | Nasdaq Stockholm (Stockholm Stock Exchange) | Central Europe, construction, Defense spending, energy transition, IIJA funding, infrastructure investment, margin expansion, Nordic construction, Order backlog quality, valuation discount | View Pitch |
| Jul 2, 2026 | Fund Letters | Protean Select | Skanska AB | Engineering & Construction | Construction & Engineering | Bull | Nasdaq Stockholm (Stockholm Stock Exchange) | construction, Defense spending, energy transition, Europe, IIJA funding, infrastructure, margin expansion, Nordics, Order backlog quality, US, Value | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||